May 17, 2020

What are the three keys of mHealth marketing?

Admin
2 min
What are the three keys of mHealth marketing .jpg
Written by Alyssa Clark Staying on top of market trends is no small task, and the penalties for falling behind can be detrimental to a companys succes...

Written by Alyssa Clark

 

Staying on top of market trends is no small task, and the penalties for falling behind can be detrimental to a company’s success in the mHealth market. For example, in 2011 only 5 percent of mobile healthcare’s traffic was generated from mobile devices; jumping ahead to 2013, the percentage has grown to 32 percent and counting. The marketing team’s role is paramount in advising its company to adhere to these market changes, by designing initiatives to match these rising demands. If this had gone unnoticed, mHealth companies would constantly be digging themselves out of these ever-changing market gaps.

Companies like Oakwood Healthcare have embraced the importance of mHealth marketing, and have capitalized on its pay-off. Mary Zatina, senior vice president of corporate communications for Oakwood, commented on the need for successful marketing ploys in mHealth:

"We're in a very competitive region," she said of her health system, which covers a 500-square-mile area, "We needed a (communications approach) that matches who they are, how they work, how they tick. … We needed to establish a much stronger relationship with people. We need to meet them on their terms."

Considering all of the above, marketing experts from the mHealth sector have agreed upon the following Top Three mHealth marketing keys:

1. Satisfied customers

2. Respected industry-wide reputation

3. Reliable and constant communication 

Share article

Jun 23, 2021

Introducing Dosis - the AI powered dosing platform

AI
medication
personalisedmedicine
chronicdisease
3 min
Dosis is an AI-powered personalised medication dosing platform that's on a mission to transform chronic disease management

Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works. 

When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing. 

The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced. 

What is the Strategic Anemia Advisor? 
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease. 

SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool. 

What else is Dosis working on? 
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs. 

What are Dosis' strategic goals for the next 2-3 years? 
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.

What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.

Share article